GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with 6-methyl UAB30 and the coactivator peptide grip-1

Analyse Crystal structure of human retinoid X receptor alpha-ligand binding domain… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4PP3
Type
protein
Length
225 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Retinoic acid receptor rxr-alpha; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
2VZ
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 69% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor rxr-alphaprotein21469% helix, 3% strandP19793
BNuclear receptor coactivator 2protein1173% helix, 0% strandQ15596

Ligands and binding sites

  • 2VZ · (2E,4E,6Z,8E)-3,7-dimethyl-8-(6-methyl-3,4-dihydronaphthalen-1(2H)-ylidene)octa-2,4,6-trienoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12260.840.96352VZ
21260.370.7321empty

Interfaces

1 interface between chains.

  • A–B · 572 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 4PP3 · Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.